tirzepatide injection burbank Weight Loss Tirzepatide (Mounjaro) In Sherman Oaks

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to a new study led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, Yale School of Medicine and other institutions.

Tirzepatide for Obesity Treatment and Diabetes Prevention "3y treatment with tirzepatide in persons with obesity and prediabetes resulted in substantial and sustained weight reduction and a lower risk (HR: 0.12) of progression to type 2 DM" @NEJM

Access compounded GLP-1 medications through Pipeline Medical

14SoWell Proteinpacks in Vanilla ($44.99 value)